Brief: Cereno Announces Extended Patent Protection In Europe For CS585 Program
09/04/2024 07:35
April 9 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* CERENO SCIENTIFIC ANNOUNCES EXTENDED PATENT PROTECTION IN
EUROPE
FOR CS585 PROGRAM
* PATENT EXPANDS PATENT PROTECTION FOR PROSTACYCLIN RECEPTOR
AGONIST PROGRAM TO ALSO INCLUDE EUROPE, ONE OF LARGEST MARKETS
FOR CARDIOVASCULAR DISEASE
Source text for Eikon: ID:nWkr7CDWgK
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global